Hexamethylmelamine (NSC-13875) in the treatment of primary cancer of the lung with metastasis.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000477:Alkylating Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy*
D000477:Alkylating Agents